Research field (5):
Hygiene and public health (non-laboratory)
, Hygiene and public health (laboratory)
, Healthcare management, medical sociology
, Pathobiochemistry
, Pharmacology
Research keywords (1):
00
Research theme for competitive and other funds (43):
2021 - 2026 ヘビの防御物質ブファジエノライド:食性進化のメカニズム解明
2019 - 2024 Tailor-maid cancer prevention towards the era of preemptive medicine.
2019 - 2023 Preventive strategy against arsenic carcinogenesis by TRAIL pathway activation and RB activation
2017 - 2022 Research of molecular-targeting prevention against inflammatory diseases using chemical biology.
2019 - 2021 Basic research for prevention of arteriosclerosis by cancer preventive ingredients with RB activation ability
2018 - 2020 A new colorectal cancer chemoprevention method to reduce side effects of aspirin
2015 - 2019 Application of molecular-targeting cancer prevention to human intervention study.
2016 - 2017 Molecular-targeting prevention against human papilloma virus-positive cervical cancer
2015 - 2016 Elucidation of the novel mechanisms of carcinogenesis induced by the cigarette and development of cancer prevention for carcinogenesis by sidestream smoke
2013 - 2016 Novel combination-oriented molecular-targeting therapy for keloid
2011 - 2012 Novel molecular-targeting prevention of cancer by sensitizing the effect of sodium butyrate
2009 - 2012 Development of micrRNA-targeting cancer prevention
2009 - 2010 GADD45を標的とした新規癌予防エピジェネティクス
2008 - 2009 TRAILとDR5を標的とした癌の「分子標的併用療法」の開発
2007 - 2008 エピジェネティックに失活した癌抑制遺伝子を標的とした新規癌予防法の開発
2005 - 2008 Research on a selection reference of chemopreventive agents for cancer and a development of tailor-made medicine for cancer prevention
片山勇輝, 谷村恵子, 森本健司, 堀中真野, 酒井敏行, 山田忠明. Mechanism of adaptive resistance to treatment with Lorlatinib via activation of EGFR signaling in ALK-rearranged non-small cell lung cancer. 日本がん分子標的治療学会学術集会プログラム・抄録集. 2022. 26th
Shogen Boku, Motoki Watanabe, Mamiko Sukeno, Takeshi Yaoi, Kiichi Hirota, Mahiro Iizuka, Kyoko Itoh, Yoshihiro Sowa, Yosuke Iizumi, Mitsuharu Masuda, et al. Combinatorial treatments of aspirin with glutaminolysis-targeting agents against PIK3CA-mutated colorectal cancer cells. ANNALS OF ONCOLOGY. 2021. 32. S309-S309
Shiori Umemura, Yoshihiro Sowa, Yosuke Iizumi, Toshiyuki Sakai. Synergistic effect of the inhibitors of RAF/MEK and AXL on KRAS-mutated ovarian cancer cells with high AXL expression. CANCER SCIENCE. 2021. 112. 771-771